Scroll To Top
Search by Speciality

2ND ANNUAL INTERNATIONAL CONGRESS ON IMMUNOTHERAPIES IN CANCER™: FOCUS ON PRACTICE-CHANGING APPLICATION

InterContinental New York Times Square | New york, USA
From 99 to 369 USD
Event Preview
-2
Days Left
For the
Event
Title: 2ND ANNUAL INTERNATIONAL CONGRESS ON IMMUNOTHERAPIES IN CANCER™: FOCUS ON PRACTICE-CHANGING APPLICATION
Specialty: Radiation Oncology
Dates: From Dec, 16, 2017 to Dec, 16, 2017
Location: New york, USA
Type: Congress
Registration Cost: From 99 to 369 USD
Event Tools
  • Add to Favorites
  • Notify me by email
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Dec
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for NEW YORK, Usa.
General Info
Event Venue:

InterContinental New York Times Square

NEW YORK, USA Visit the Venue to read more
Currency:
USD
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

The development of immunotherapies to treat cancer has transformed the way clinicians think about managing their patients with many forms of malignancies. The speed at which basic science and clinical trial information continue to emerge in this area, however, creates practice and/or educational gaps for busy clinicians who strive to maintain state-of-the art care for their patients with cancer. This field is one of the most clinically relevant and exciting areas of novel drug development in oncology.


“But how do I use this information to manage my patients with cancer?”


This is the key question, and the one whose answer ultimately means the most to your patients. The 2nd Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing Application will do just that, by answering that question. This exciting and fast-paced Congress will provide a multi-module curriculum-based program that focuses exclusively on immunotherapies and their application to the management of cancer. This intensive, 1-day interactive program will provide a comprehensive review of the key data sets that are most relevant to the application of these novel strategies for the clinician who manages some of the most difficult-to-treat forms of cancer. The program will focus on the practical application of recent clinical trial results that have shaped current and evolving clinical management, evolving biomarker information, the latest basic science findings, and the most highly anticipated clinical trials in the field.



Target Audience


This educational program is directed toward oncologists, nurses, and pharmacists. Participants will be primarily those whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on immunotherapies and their evolving roles in the treatment of cancer.



Learning Objectives


After completing this educational activity, the participants will be able to:


Explain current and evolving mechanistic approaches concerning how the immune system can be targeted in the treatment of cancer.

Evaluate clinical trial findings on immuno-oncology strategies and how they can be practically applied to the management of cancer in multiple lines of care.

Discuss emerging methods to personalize care via the use of biomarkers and other methods to individualize the use of immuno-oncology strategies.

Describe how common and uncommon adverse events, associated with the use of immuno-oncology strategies, can be proactively mitigated and managed.

Detail important remaining clinical questions in the field, and highly anticipated ongoing clinical trials, that are evaluating emerging immuno-oncology strategies.

Speakers/Faculty:

Arjun V. Balar, MD

Director of GU Medical Oncology, Laura and Isaac Perlmutter Cancer Center

Assistant Professor

NYU Langone Medical Center

New York, NY

 

Julie Brahmer, MD

Co-Director of the Upper Aerodigestive Department within the Bloomberg~Kimmel Institute for Cancer Immunotherapy

Associate Professor of Oncology

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Baltimore, MD

 

Charles Drake, MD, PhD

Professor of Oncology and Immunology

Director, Genitourinary Cancer Program

Co-director of the Immunotherapy Program

Herbert Irving Comprehensive Cancer Center

Columbia University Medical Center

New York, New York, USA

 

Dung Le, MD

Associate Professor of Oncology

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Baltimore, MD

 

David F. McDermott, MD

Associate Professor, Medicine

Harvard Medical School

Staff Physician, Hematology/Oncology

Director, Biologic Therapy and Cutaneous Oncology Programs, Hematology/Oncology

Beth Israel Deaconess Medical Center

Boston, MA

 

David L. Porter, MD

Jodi Fisher Horowitz Professor in Leukemia Care Excellence

Director, Blood and Marrow Transplantation

Hospital of the University of Pennsylvania

Philadelphia, PA

 

Michael A. Postow, MD

Medical Oncologist

Memorial Sloan Kettering Cancer Center

New York, NY

 

Tanguy Y. Seiwert, MD 

Medical Oncologist

The University of Chicago Medicine

Chicago, IL

 

Janice M. Taube, MD

Director of Dermatopathology Division and Fellowship

Associate Professor of Dermatology, Pathology, and Oncology

Johns Hopkins University SOM

Baltimore, MD

 

Jeffrey S. Weber, MD, PhD

Deputy Director

Laura and Isaac Perlmutter Cancer Center

Professor of Medicine

NYU Langone Medical Center

New York, NY

 

E. John Wherry, PhD

Director, Institute for Immunology

Professor, Microbiology

University of Pennsylvania

Philadelphia, PA

Registration Needs updating Register Now
Currency:

AUD

Registration Cost
Type
Early Registration

2017-08-26
Late Registration From: 2017-08-27 To: 0--
On site Registration
Registration
99
149
0
Industry
319
369
0

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation
Accommodation:

InterContinental New York Times Square

300 W 44th St, New York, NY 10036

Phone: (212) 803-4500


Be sure to mention the 2nd Annual International Congress on Immunotherapies in Cancer when making reservations to receive the discounted rate.


Location

The InterContinental New York Times Square is located near Grand Central Station. It is also conveniently located near La Guardia Airport (LGA), John F. Kennedy Airport (JFK), and Newark Liberty International Airport (EWR).


Room Rates

All room rates are subject to applicable state and local taxes.


Superior King | Double: $479 (single/double rate).


The deadline for making your discounted hotel reservations is November 10, 2017. After that date, or in the event that the room block becomes full prior to the deadline, rooms are subject to availability and the room rates may increase.

Accommodation Options and Cost

Hotel Name
Type of charge
Single
Room
Double
Room
Distance from Venue
InterContinental New York
Date range
479
Scientific Content Up to Date
Submission Info
Sponsors Exhibitors
General Info

Physicians' Education Resource, LLC

Phone: 609-378-3701

Fax: 609-257-0705

Email: info@gotoper.com

Contact
Organising Agency

Physicians' Education Resource, LLC

Phone: 609-378-3701

Fax: 609-257-0705

Email: info@gotoper.com

Event map
Revelant Events